20 articles
Early high-fat, high-sugar diets alter brain appetite circuits long-term, but probiotics and prebiotics may help undo the harm.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
A proteomics study tracking 3,000 blood proteins reveals fasting's deepest benefits emerge only after 72 hours without food.
A new study finds intermittent fasting triggers coordinated changes in gut microbiome and brain regions controlling appetite and cravings.
A key fat metabolism protein works inside cell nuclei to keep fat tissue healthy — its absence causes fat loss, not gain.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
Disabling the MTCH2 protein in human cells supercharges fat burning and halts new fat cell growth — a potential obesity breakthrough.
University of Sydney researchers found that cutting fat or animal protein for just four weeks lowered biological age markers in older adults.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
Most genetic variants explain only a few percent of nutritional differences between people, yet companies market expensive personalized plans.
UCLA researchers eliminated senescent immune cells in mice, dramatically reversing liver damage even without diet changes.
Scientists found astrocytes, not just neurons, control when you feel full after eating through a newly discovered glucose-sensing pathway.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
A newly identified trigger in brown fat activates a hidden calorie-burning pathway and may unlock new treatments for bone disease.
Japanese scientists engineered hybrid vitamin K molecules that are 3x more potent at regrowing neurons, potentially transforming Alzheimer's treatment.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
Scientists identify a new type of stem cell that activates with aging and supercharges belly fat production, opening anti-obesity targets.
